AFP and hepatocellular carcinoma: Considering both the benefits and harms related to surveillance, utilizing ultrasounds in conjunction with AFP testing proved to be a more cost-effective approach for monitoring HCC than relying on ultrasounds alone or foregoing surveillance entirely in individuals with compensated cirrhosis [65].